Perelel, the five-year-old supplement brand, announced a $27 million round in funding, led by Prelude Growth Partners. Additional investors were Unilever Ventures, Willow Growth Partners and Selva Ventures, which previously participated in its Series A round in 2024.
Launched by Victoria Thain Gioia, Alex Taylor and obsetrician and gynecologist Dr. Banafsheh Bayati, Perelel was created to provide quality prenatal vitamins in a market where the product is recommended by doctors yet not regulated as drugs. The brand has since expanded into other categories like perimenopause, hormones and fertility.
The brand’s “doctor-founding coupled with its clinical validation and commitment to women’s health research” attracted Prelude to the investment, said Neda Daneshzadeh, co-founder and managing partner in a statement. The firm has invested in several beauty and wellness brands that have achieved exits, including Sol de Janeiro, Naturium and Phlur.
Beauty’s Great Menopause Conundrum
Over the past half decade, beauty has attempted to ride the menopause wave with mixed results. A new crop of brands is seeking success by embracing hormones, ageing Millennials and telemedicine.
